Aligning with NHS Goals.
The UK Government has announced that by 2029, the NHS will roll out lung health screening checks across the country. However, the additional resources required to achieve this goal are significant, particularly at a time when the NHS is facing intense pressure. AI technologies like Optellum's could help health systems "tilt towards technology" and achieve their goals without overburdening already stretched radiology and pulmonology departments.

Carlos Arteta, Head of Core Machine Learning at Optellum, added:
"This technology offers the NHS a pathway to achieving its long-term lung cancer screening goals without adding additional burdens to already overstretched radiology and pulmonology resources. By integrating AI into routine diagnostic workflows, we can help ensure that more patients receive earlier diagnoses and timely interventions."

To learn more about the study (NIHR207547), read the full press release:
https://www.gov.uk/government/news/new-government-tech-deals-boost-the-business-of-cancer-detection
https://www.nihr.ac.uk/news/nihr-and-office-life-sciences-fund-new-projects-drive-earlier-diagnosis-cancer


About Optellum
Optellum is a commercial-stage lung health company providing AI-powered decision-support software that assists physicians in early diagnosis and optimal treatment for patients. The company was founded so that every lung disease patient could be diagnosed and treated at the earliest possible stage, when the probability of better health outcomes is highest.

Optellum is the leader in AI-enabled lung cancer diagnosis, and the first and only medtech company to have attained FDA 510(k) clearance, CE-MDR in the EU, and UKCA in the UK for its software platform, Virtual Nodule Clinic.
Optellum is located at the Oxford Centre for Innovation in Oxford, United Kingdom and in the US at the Texas Medical Center in Houston, Texas.

About NIHR
The mission of the National Institute for Health and Care Research (NIHR) is to improve the health and wealth of the nation through research. We do this by:
• Funding high quality, timely research that benefits the NHS, public health and social care;
• Investing in world-class expertise, facilities and a skilled delivery workforce to translate discoveries into improved treatments and services;
• Partnering with patients, service users, carers and communities, improving the relevance, quality and impact of our research;
• Attracting, training and supporting the best researchers to tackle complex health and social care challenges;

US Press Room Homepage